Currently, between 65,000 to 70,000 cases of cancers in adolescents and young adults (aged 15 to 39) are diagnosed each year in the United States. Among the different types of, thyroid cancer has emerged...

The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive...